Objective-To determine whether women with rheumatoid arthritis (RA) 
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Methods
The population for this study has been described in detail previously. 15 not shown). Table 5 shows the percentages of siblings ever having taken the pill. For this data, only 17 pairs of sisters had one or both members with a history of ever having taken the pill. Although it was more common for the sibling without RA rather than the sibling with RA to have taken the pill in both the HLA nonidentical and identical sibling pairs, these differences were not significant. Table 6 shows the percentages of siblings who were nulliparous. There were no significant differences between the groups. Differences in the mean ages of first pregnancy within the pairs were not significant (siblings with RA v siblings without RA 23-2 (SD 3 1) years v 24A4
(SD 3 9) years). This finding applied to both the identical and non-identical HLA pairs.
Discussion
The sister pairs have provided a potentially informative population to investigate further previously described epidemiological associations with RA. The opportunity to investigate HIA identity also enabled us to analyse possible interactions between HIA linked factors and reproductive variables. By making comparisons within sibships, it is also possible to ensure a greater similarity of other social and environmental variables than is the case in unrelated control groups. Our population was not ideal for considering the role of the contraceptive pill, as most of our sibling pairs had never taken the pill. This presumably reflects the age of the population and unavailability of the pill during their reproductive years. For those pairs in whom at least one member had ever taken the pill, there was a tendency in both the identical HLA and non-identical HLA pairs for the sibling without RA to have been ever exposed more often than the sibling with RA. These data are not incompatible with the possibility that the contraceptive pill confers a mild protective effect on the predisposition to RA.4 Another study considering the use of the pill in pairs of sisters came to similar conclusions.'7
Our study does not support the protective effect of pregnancy on RA in that we found similar frequencies of nulliparity in the siblings with and without RA. Although recent studies on RA and unrelated controls have suggested a predisposing effect for nulliparity3 " and one study suggested a protective effect from an early first pregnancy,'8 these results have not been reproduced in all studies.'2 Doubt has to remain, therefore, on the role of pregnancy in influencing the pathogenesis of RA. In agreement with most recent studies,3 18 19 we failed to support a role for adverse pregnancy outcome in RA. The principal contribution of the present study has been in highlighting a possible role for interactions between delayed menarche, RA, and HLA linked factors.
The main problem in determining the age of menarche retrospectively is that of accurate recall and the discrepancies between subjects as to when the periods are defined as starting. A recent study suggested that 84% of women could recall the age of menarche to within one year of the event.20 Moreover, we can think of no reason why the biases introduced by inaccurate recall should be any greater in siblings who go on to develop RA than in their sisters without RA.
The finding that a delayed menarche is associated with development of RA needs to be confirmed in other populations. Spector 25 testosterone concentrations. These findings raise the possibility that genes within the major histocompatibility complex may be important in determining phenotypic variants that could exert a profound effect over characteristics such as the age of the menarche. This needs to be studied in healthy sibling populations. Such a study would have to be of a reasonable size, as in 117 sibships we found that HLA haplotype sharing was not a significant predictor of interpair differences in age of menarche. This is probably a reflection of the many environmental and possibly other genetic factors that determine this event.
In summary, this study raises some interesting possibilities. The first is that delayed menarche predisposes to, or is a marker of, RA 
